Quhuo Limited (OTC: QHUOY) ("Quhuo" or the "Company"), a leading gig economy platform focusing on local life services, today announced that it will change the ratio of its American Depositary Shares ( ...
Biodexa Pharmaceuticals PLC, an acquisition-focused clinical stage biopharmaceutical company developing a pipeline of innovative products for the treatment of diseases with unmet medical needs, today ...
SHANGHAI, Jan. 10, 2025 /PRNewswire/ -- Boqii Holding Limited ("Boqii" or the "Company") (NYSE American: BQ) today announced that it will change its ratio of its American Depositary Shares ("ADSs") to ...
RAMAT GAN, ISRAEL, March 20, 2026 (GLOBE NEWSWIRE)-- XTL Biopharmaceuticals Ltd. (Nasdaq:XTLB) (TASE:XTLB.TA) (the “Company” or “XTL”), announced today that it plans to change the ratio of its ...
DUBLIN and BRIDGEWATER, N.J., April 09, 2025 (GLOBE NEWSWIRE) -- Amarin Corporation plc (NASDAQ: AMRN), today confirmed that April 11, 2025 will be the effective date for the Company’s previously ...
TAMPA, Fla. and LONDON, March 17, 2026 (GLOBE NEWSWIRE) -- Akari Therapeutics, Plc (Nasdaq: AKTX), an oncology biotechnology company developing antibody drug conjugates (ADCs) with novel RNA splice ...
111, Inc. announced that it plans to change the ratio of its American Depositary Shares to Class A ordinary shares from one ADS representing two Class A ordinary shares to the new ratio of one ADS ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results